NeuroOne Medical Technologies Corporation
NMTC
$0.80
-$0.01-0.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.89M | 5.74M | 1.70M | 1.39M | 3.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.89M | 5.74M | 1.70M | 1.39M | 3.27M |
| Cost of Revenue | 2.71M | 2.33M | 1.96M | 670.10K | 2.52M |
| Gross Profit | 178.10K | 3.41M | -267.70K | 716.50K | 754.70K |
| SG&A Expenses | 1.89M | 1.78M | 1.62M | 1.94M | 2.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 3.00M | -- | -- | -3.00M |
| Total Operating Expenses | 4.60M | 7.11M | 3.58M | 4.07M | 1.56M |
| Operating Income | -1.71M | -1.37M | -1.89M | -2.68M | 1.71M |
| Income Before Tax | -1.44M | -1.62M | -1.50M | -2.27M | 1.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.44M | -1.62M | -1.50M | -2.27M | 1.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.44M | -1.62M | -1.50M | -2.27M | 1.79M |
| EBIT | -1.71M | -1.37M | -1.89M | -2.68M | 1.71M |
| EBITDA | -1.64M | -1.31M | -1.82M | -2.61M | 1.78M |
| EPS Basic | -0.03 | -0.03 | -0.03 | -0.07 | 0.06 |
| Normalized Basic EPS | -0.02 | -0.01 | -0.02 | -0.05 | 0.03 |
| EPS Diluted | -0.03 | -0.03 | -0.03 | -0.07 | 0.06 |
| Normalized Diluted EPS | -0.02 | -0.01 | -0.02 | -0.05 | 0.03 |
| Average Basic Shares Outstanding | 50.33M | 50.06M | 48.61M | 31.11M | 30.84M |
| Average Diluted Shares Outstanding | 50.33M | 50.06M | 48.61M | 31.11M | 30.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |